HBIO
Harvard Bioscience Inc (HBIO)
Healthcare • NASDAQ • $6.90+1.55%
- Symbol
- HBIO
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $6.90
- Daily Change
- +1.55%
- Market Cap
- $31.10M
- Trailing P/E
- N/A
- Forward P/E
- 8.41
- 52W High
- $9.50
- 52W Low
- $2.80
- Analyst Target
- $6.00
- Dividend Yield
- N/A
- Beta
- 1.57
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data fr…
Company websiteResearch HBIO on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.